Full Product Details
Author: Eric B. Holmgren
Publisher: Taylor & Francis Ltd
Imprint: CRC Press
Weight: 0.490kg
ISBN: 9781138374683
ISBN 10: 1138374687
Pages: 261
Publication Date: 18 September 2018
Audience:
College/higher education
,
General/trade
,
Tertiary & Higher Education
,
General
Format: Paperback
Publisher's Status: Active
Availability: In Print
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.
Reviews
'In each chapter, author provides appropriate statistical formulas that readers can actually utilize. Since this book handles many mathematical formulas, and contains many real good examples, this book would be very useful for statisticians who work at pharmaceutical companies and are deeply involved with drug development ... Overall, this book covers necessary and important aspects for drug development, and would be quite useful to clinical statisticians. ' -Byung-Ho Nam, PhD, Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Korea, in Biometrics The given book presents a theory of drug development that is based on maximizing the efficiency with which drugs that truly provide clinical benefits are identified. The author shows how to optimize the drug development process at its three main stages (Phases 1, 2, 3), and at some transitional sub-stages, so that the number of molecules that result in a positive final Phase 3 clinical trial per investment is maximized. -Fatima T. Adylova in Zentralblatt MATH
""’In each chapter, author provides appropriate statistical formulas that readers can actually utilize. Since this book handles many mathematical formulas, and contains many real good examples, this book would be very useful for statisticians who work at pharmaceutical companies and are deeply involved with drug development … Overall, this book covers necessary and important aspects for drug development, and would be quite useful to clinical statisticians.""’ —Byung-Ho Nam, PhD, Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Korea, in Biometrics ""The given book presents a theory of drug development that is based on maximizing the efficiency with which drugs that truly provide clinical benefits are identified. The author shows how to optimize the drug development process at its three main stages (Phases 1, 2, 3), and at some transitional sub-stages, so that the number of molecules that result in a positive final Phase 3 clinical trial per investment is maximized."" —Fatima T. Adylova in Zentralblatt MATH ""’In each chapter, author provides appropriate statistical formulas that readers can actually utilize. Since this book handles many mathematical formulas, and contains many real good examples, this book would be very useful for statisticians who work at pharmaceutical companies and are deeply involved with drug development … Overall, this book covers necessary and important aspects for drug development, and would be quite useful to clinical statisticians.""’ —Byung-Ho Nam, PhD, Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Korea, in Biometrics ""The given book presents a theory of drug development that is based on maximizing the efficiency with which drugs that truly provide clinical benefits are identified. The author shows how to optimize the drug development process at its three main stages (Phases 1, 2, 3), and at some transitional sub-stages, so that the number of molecules that result in a positive final Phase 3 clinical trial per investment is maximized."" —Fatima T. Adylova in Zentralblatt MATH
Author Information
Eric B. Holmgren is a consultant and statistical scientist. He previously worked at Genentech and Hoechst Roussel Pharmaceuticals. He received a Ph.D. in mathematical statistics from Stanford University.
